Cincinnati, OH, United States of America

Thomas Ward Osborn, Iii

This inventor holds 130 USPTO granted patents and 5 published patent applications, primarily in Feminine Hygiene Products (CPC class 6043851). Top assignees: The Procter Gamble Company, The Proctor 'Gamble Company, Other. Active years: 1982-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Ward Osborn, Iii. Retrieved from https://idiyas.com/inventor/thomas-ward-osborn-iii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 130 

% Patents Active = 91.5

Average Co-Inventor Count = 2.4

ph-index = 40

Forward Citations = 5,152(Granted Patents)

Forward Citations (Not Self Cited) = 4,893(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Cincinnatti, OH (US) (1998 - 1999)
  • Clifton, OH (US) (2007 - 2014)
  • Cincinnati, OH (US) (1982 - 2015)

Company Filing History:


Years Active: 1982-2015

Loading Chart...
Areas of Expertise:
Tampon
Absorbent Article
Feminine Hygiene Kit
In Vitro Testing
Dynamic Location
Asymmetric Insertion
Leakage Protection
Interlabial Device
Computational Model
Soft Conformable
Highly Efficient
Sanitary Napkin
130 patents (USPTO):Explore Patents

Title: Thomas Ward Osborn III: Innovator Extraordinaire

Introduction:

Thomas Ward Osborn III is a highly accomplished inventor hailing from Cincinnati, OH. With an astonishing number of 129 patents under his belt, Osborn has made significant contributions in the fields of healthcare and personal hygiene. His latest patents, focused on reducing the production of toxic shock syndrome toxin-1 in articles and improving tampon design, showcase his dedication to creating innovative solutions for everyday challenges.

Latest Patents:

Osborn's recent patents include groundbreaking advancements in healthcare and feminine hygiene. One of his notable inventions is an article comprising calcium for reducing the production of TSST-1. By incorporating one or more calcium salts, these articles effectively reduce the production of TSST-1 by at least 50% when measured by the Shake Flask Method. Importantly, the calcium salts used are substantially non-lethal, making them safe for use.

In addition, Osborn has also developed a tampon featuring a plurality of strips or cords. This design innovation enhances absorbency and comfort. The tampon body, with its first end, second end, center portion, longitudinal axis, and radial axis, incorporates strips or cords made from various materials such as films, woven materials, absorbent foams, superabsorbent polymers, or mixtures thereof. This novel tampon design offers improved functionality and effectiveness.

Career Highlights:

Throughout his career, Osborn has made significant contributions while working with The Procter & Gamble Company (P&G) and its subsidiary, The Proctor & Gamble Co. (P&G Co.). His extensive experience and expertise in inventing and developing consumer products have greatly impacted the industry. With his patents covering diverse areas of everyday life, from healthcare to personal care products, Osborn has played a vital role in shaping innovation in these sectors.

Collaborations:

Osborn's successful career has been marked by fruitful collaborations with esteemed colleagues. Among his notable coworkers are Letha Margie Hines and Bruce William Lavash. These collaborations have fostered a dynamic environment for idea exchange and innovation within the industry, leading to the development of groundbreaking inventions.

Conclusion:

Thomas Ward Osborn III is an exemplary innovator, whose extensive patent portfolio reflects his commitment to enhancing healthcare and personal hygiene products. His remarkable contributions stand as a testament to his creativity, technical expertise, and dedication to improving lives through innovation. As Osborn's journey continues, one can only anticipate the emergence of further ingenious solutions from this brilliant mind.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…